209 related articles for article (PubMed ID: 38184120)
1. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.
Zhou W; Lim A; Elmadbouh OHM; Edderkaoui M; Osipov A; Mathison AJ; Urrutia R; Liu T; Wang Q; Pandol SJ
Free Radic Biol Med; 2024 Feb; 212():493-504. PubMed ID: 38184120
[TBL] [Abstract][Full Text] [Related]
2. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells.
Wang XW; Yang ZY; Li T; Zhao XR; Li XZ; Wang XX
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37751128
[TBL] [Abstract][Full Text] [Related]
3. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.
Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J
Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma.
Yang C; Dong Q; Bao H; Ge Y; Xu Z; Li J; Jiang X; Xu Y; Zhong X
Front Biosci (Landmark Ed); 2024 Jan; 29(1):45. PubMed ID: 38287825
[TBL] [Abstract][Full Text] [Related]
5. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Hippo/YAP signaling pathway ameliorates cochlear hair cell injury by regulating ferroptosis.
Niu X; Han P; Liu J; Chen Z; Ma X; Zhang T; Li B; Ma X
Tissue Cell; 2023 Jun; 82():102051. PubMed ID: 36889225
[TBL] [Abstract][Full Text] [Related]
7. Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis.
Zhong L; Meng X; Huang J; Hao W; Zuo Y
Chin Clin Oncol; 2023 Oct; 12(5):52. PubMed ID: 37964544
[TBL] [Abstract][Full Text] [Related]
8. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
9. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs).
Delvaux M; Hagué P; Craciun L; Wozniak A; Demetter P; Schöffski P; Erneux C; Vanderwinden JM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291834
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
Wei C; Li X
BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
[TBL] [Abstract][Full Text] [Related]
12. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
13. The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.
Wei C; Li X
Front Pharmacol; 2020; 11():557429. PubMed ID: 33178014
[TBL] [Abstract][Full Text] [Related]
14. Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells.
Wei C; Li X
Mol Med Rep; 2020 Nov; 22(5):3955-3961. PubMed ID: 32901856
[TBL] [Abstract][Full Text] [Related]
15. Notch3 regulates ferroptosis via ROS-induced lipid peroxidation in NSCLC cells.
Li Z; Xiao J; Liu M; Cui J; Lian B; Sun Y; Li C
FEBS Open Bio; 2022 Jun; 12(6):1197-1205. PubMed ID: 35258176
[TBL] [Abstract][Full Text] [Related]
16. Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future.
Li C; Yin X; Liu Z; Wang J
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499358
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
Dong L; Lin F; Wu W; Liu Y; Huang W
Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256
[TBL] [Abstract][Full Text] [Related]
18. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
[TBL] [Abstract][Full Text] [Related]
19. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells.
Kuang F; Liu J; Xie Y; Tang D; Kang R
Cell Chem Biol; 2021 Jun; 28(6):765-775.e5. PubMed ID: 33539732
[TBL] [Abstract][Full Text] [Related]
20. Apatinib induced ferroptosis by lipid peroxidation in gastric cancer.
Zhao L; Peng Y; He S; Li R; Wang Z; Huang J; Lei X; Li G; Ma Q
Gastric Cancer; 2021 May; 24(3):642-654. PubMed ID: 33544270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
